文献速递耳科与耳神经

鼓室内凝胶治疗内耳疾病:临床试验范围综述

Intratympanic Gels for Inner Ear Disorders: A Scoping Review of Clinical Trials.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-02-03

本范围综述遵循PRISMA标准,检索1990至2022年Google scholar、PubMed及临床试验注册库,纳入45项经鼓室内注射凝胶制剂治疗内耳疾病的临床试验。凝胶形式为泊洛沙姆或透明质酸组合,靶向获得性稳定感音神经性聋、耳鸣、急性突发性感音神经性聋、梅尼埃病、顺铂诱导耳毒性及人工耳蜗植入术听力保留。部分研究仅报告“凝胶”或“热凝胶”载体而未明确具体制剂;需更大规模及更高级别临床试验确认疗效。

要点

  • 鼓室内注射凝胶可经圆窗膜向内耳延长药物释放,为内耳疾病局部治疗提供途径。
  • 纳入45项临床试验,凝胶类型主要为泊洛沙姆或透明质酸组合,覆盖多种内耳适应症。
  • 部分研究未明确具体凝胶制剂,仅以“凝胶”或“热凝胶”描述递送载体。

核心结论

  • 多种临床试验通过泊洛沙姆和透明质酸制剂注射不同化合物靶向治疗多种形式的内耳疾病。
  • 部分列入研究未提供所用凝胶制剂的具体类型,仅报告鼓室内递送载体为“凝胶”或“热凝胶”。
  • 需要更大规模及更高级别临床阶段的研究来确认这些化合物的疗效。

研究设计与样本

  • 范围综述,遵循PRISMA标准,检索1990年至2022年Google scholar、PubMed、Clinicaltrials.gov及Euclinicaltrial注册库。
  • 纳入标准为经局部鼓室内注射给药、靶向内耳疾病且测试凝胶制剂的临床试验。
  • 由作者成对工作、序贯筛选仅符合纳入标准的研究,共识别45项临床研究。

主要发现

  • 共识别45项临床研究,鼓室内注射用凝胶形式为泊洛沙姆或透明质酸组合。
  • 试验靶向的内耳疾病包括获得性稳定感音神经性聋、耳鸣、急性突发性感音神经性聋、梅尼埃病、顺铂诱导耳毒性及人工耳蜗植入手术患者的听力保留。
  • 部分列入研究未提供所用凝胶制剂的具体类型,仅报告鼓室内递送载体为“凝胶”或“热凝胶”。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更大规模及更高级别临床阶段的研究来确认这些化合物的疗效。
  • 部分列入研究未提供所用凝胶制剂的具体类型,仅报告鼓室内递送载体为“凝胶”或“热凝胶”。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intratympanic injections are a safe, well tolerated procedure routinely performed by ENT's specialists. Intratympanic injections of gels have the potential to deliver therapeutics into the cochlea through the round window membrane prolonging the release of drugs in the inner ear compartment. Aim of the present review is to summarize clinical trials testing pharmacological treatments for inner ear pathologies through intratympanic gel formulations. DATA SOURCES: Online databases (Google scholar and PubMed) and registers (Clinicaltrials.gov and Euclinicaltrial) were used to identify clinical trials performed between 1990 and 2022. REVIEW METHODS: PRISMA criteria have been followed. Clinical trials testing gel formulations administered through local intratympanic injections and targeting inner ear disorders were included. All the reports were identified by the authors working in pairs sequentially selecting only studies respecting the inclusion criteria. RESULTS: A total of 45 clinical studies have been noticed; the gels for intratympanic injection are in the form of poloxamers or hyaluronic acid combinations; the trials found target different kind of inner ear disorders: acquired-stable SNHL, tinnitus, acute sudden SNHL, Meniere disease, cisplatin induced ototoxicity and hearing preservation in patients undergoing cochlear implant surgery. CONCLUSION: Few studies listed do not provide the specific kind of gel formulation used but only report the intratympanic delivery vehicle as "gel" or "thermogel". Multiple clinical studies have been targeting several forms of inner ear disorders by injecting different compounds through poloxamer and hyaluronic acid formulations. Larger and more advanced clinical stages are necessary to confirm the efficacy of these chemical compounds.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Brotto D, Greggio M. Intratympanic Gels for Inner Ear Disorders: A Scoping Review of Clinical Trials. Otolaryngol Head Neck Surg. 2024. PMID: 38308599. doi:10.1002/ohn.656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。